Sign in
Mark Sheahan

Mark Sheahan

President and Chief Executive Officer at GRACOGRACO
CEO
Executive
Board

About Mark Sheahan

Mark W. Sheahan, 60, is Graco’s President and Chief Executive Officer (CEO) and a director, roles he has held since June 2021 after joining the company in 1995; his prior roles include CFO & Treasurer (2018–2021), VP/GM Applied Fluid Technologies (2008–2018), Chief Administrative Officer (2005–2008), and Vice President & Treasurer (1998–2005) . He also serves as a director of Tennant Company and on the board of managers of Fernweh Group, LLC . Under the SEC “Pay vs. Performance” disclosure, Graco reported net sales of $2,143.5m (2022), $2,195.6m (2023), and $2,133.3m (2024), net income of $460.6m (2022), $506.5m (2023), and $486.1m (2024), and a $100 TSR value of $134 (2022), $175 (2023), and $171 (2024) .

Past Roles

OrganizationRoleYearsStrategic impact
Graco Inc.President & CEO; DirectorJun 2021–presentLeadership continuity; capital allocation and strategy oversight as CEO/director .
Graco Inc.CFO & Treasurer2018–2021Financial leadership through multi-year growth cycle .
Graco Inc.VP & GM, Applied Fluid Technologies2008–2018P&L leadership for key growth platform .
Graco Inc.Chief Administrative Officer2005–2008Enterprise administration and operations support .
Graco Inc.VP & Treasurer1998–2005Balance sheet and capital structure stewardship .
Graco Inc.Manager, Treasury Servicespre-1996–1996Treasury operations and liquidity management .

External Roles

OrganizationRoleYearsStrategic impact
Tennant CompanyDirectorCurrentCross-industry insights; governance and strategy .
Fernweh Group, LLCBoard of ManagersCurrentIndustrial/industrial-tech investment perspectives .

Fixed Compensation

Metric202220232024
Base Salary ($)918,800 985,000 1,025,000
Target Bonus (% of base)100% (CEO plan design) 100% (CEO plan design) 100% (CEO plan design)
Actual Annual Bonus ($)788,695 1,299,436 122,740
Actual Payout vs Target (%)132% 12%
  • 2024 base increased 4% to $1,025,000 (from December 2023 review) .
  • Perquisites and benefits: executive financial planning reimbursement (CEO up to $10,000 in 2024), executive physical program, supplemental long-term disability (up to $21,800/month), and limited spousal travel reimbursements with potential tax gross-ups .

Performance Compensation

Annual Cash Incentive Plan (metrics, weightings, and outcomes)

  • Design: corporate Net Sales and corporate Incentive EPS for CEO (and corporate/division/region metrics for others) .
  • 2023 outcomes (CEO): payout 132% of target (132% of base salary) .
YearMetricWeightTarget DefinitionThreshold (% of Target)Maximum (% of Target)Actual vs TargetCEO Payout
2023Corporate Net Sales40% 102% of 2022 actual 90% 105% 100% 132% of target (132% of base)
2023Corporate Incentive EPS60% 102% of 2022 actual 90% 105% 113% 132% of target (132% of base)
2024Corporate Net Sales, Incentive EPSDesign unchanged CEO payout 12% of target (12% of base) 12% (12% of base)

Long-Term Incentives (stock options only)

  • Philosophy: stock options are the sole executive LTI, granted near the 75th percentile of market data, 10-year term, 4-year ratable vesting; repricing prohibited .
  • Recent CEO grants and key terms:
GrantOptions (#)Exercise Price ($/sh)TermVestingGrant Date Fair Value ($)
Feb 16, 2024189,910 88.64 10 years 25% annually over 4 years 5,499,794
Feb 17, 2023245,530 (unexercisable at 12/29/2023) 71.47 10 years 25% annually over 4 years Option Awards $5,499,872 (SCT value)
Feb 2025204,910 (2025 grant) FMV on grant (policy) 10 years 25% annually over 4 years
  • Option exercises (liquidity/pressure indicators): 0 shares exercised in 2023; 43,080 shares exercised in 2024 for $2,517,449 value realized .

Equity Ownership & Alignment

ItemDetail
Beneficial ownership (Feb 24, 2025)861,857 shares; includes 762,066 shares acquirable via vested stock options; includes 2,892 shares held by spouse; less than 1% of outstanding shares .
Stock ownership guidelinesCEO must hold ≥5x base salary; retain 50% of net shares from equity awards until guideline met .
Equity vehicle mixOptions only for executives (rare use of restricted stock historically) .

Outstanding equity awards at FY-end (retention overhang and vesting runway):

Grant DateExercisable (#)Unexercisable (#)Exercise Price ($)Expiration
2/16/20240 189,910 88.64 2/16/2034
2/17/202361,382 184,148 71.47 2/17/2033
2/18/2022118,045 118,045 71.73 2/18/2032
6/10/2021103,117 34,373 73.70 6/10/2031

Employment Terms

  • Key Employee Agreement (pre-Change-in-Control): if terminated involuntarily without cause, CEO receives pro-rata bonus (based on actual performance), severance equal to 2× (base salary + target bonus), continued medical/dental/life up to 18 months, outplacement, and legal fee reimbursement if prevailing .
  • Change-in-Control (double-trigger within 2 years): pro-rata bonus at target and severance equal to 3× (base salary + target bonus); unvested stock options and restricted stock accelerate upon Change in Control (and for death/disability as specified) .
  • Retirement, disability, death: pro-rata bonus and equity vesting provisions as disclosed; participation in the Employee Retirement Plan and the Restoration Plan; pension benefits per plan .
  • Clawbacks/recoupment: NYSE-compliant Incentive Compensation Recovery Policy (restatements) and separate Executive Officer Misconduct Recoupment Policy (3-year look-back); awards subject to forfeiture/recovery under plan terms .

Potential payments (aggregated) as of the stated dates:

ScenarioDec 29, 2023Dec 27, 2024
Involuntary (Not for Cause) or Good Reason Following Change of Control$13,024,937 $9,544,229
Involuntary (Not for Cause)$4,366,634 $4,649,263
Retirement$389,100 $509,100
Death$1,374,100 $1,009,100
Disability$642,276 $762,276

Board Governance and Director Role

  • Board service: director since June 2021 .
  • Board leadership and independence context: the Board Chair is J. Kevin Gilligan (non-CEO), indicating CEO and Chair roles are separated; Sheahan is a management director (inside director) while MOCC oversight is led by independent director Martha A. Morfitt (MOCC Chair) .
  • Proxies provide full committee composition; CEO biographies do not list committee memberships, consistent with typical practice that executives do not serve on audit/compensation/governance committees .

Performance & Track Record

Metric202220232024
Net Sales ($ thousands)2,143,521 2,195,606 2,133,316
Net Income ($ thousands)460,645 506,511 486,084
$100 TSR Value (Company)134 175 171
$100 TSR Value (Peer Group)126 160 177

Say-on-Pay & Shareholder Feedback

  • Say-on-pay support: 88.6% (April 2022) and 89.7% (April 2023); Board continues to target competitive, performance-oriented pay structures .
  • Annual advisory vote on NEO compensation continues (2025 proxy) .

Investment Implications

  • Alignment and incentive quality: Options-only LTI with four-year ratable vesting and no repricing tightly aligns realized pay with long-term TSR and share price compounding; MOCC targets ~75th percentile LTI value, underscoring retention and outperformance ambitions .
  • Cyclicality discipline: 2024 annual bonus paid at just 12% of target (vs. 132% in 2023), reflecting under-target results on Net Sales/Incentive EPS and signaling meaningful downside variability in cash pay when growth moderates .
  • Ownership and selling pressure: Sheahan beneficially owns 861,857 shares (including vested options) with <1% ownership of shares outstanding; exercises in 2024 (43,080 shares; ~$2.52m realized) vs. zero in 2023 suggest manageable liquidity rather than persistent selling pressure; additional unvested option overhang supports retention through 2028–2034 expiries .
  • Downside protections and change-in-control: Double-trigger 3× (base+target bonus) and equity acceleration are standard but sizable; investors should monitor potential M&A scenarios for payout dynamics .
  • Governance mitigants: CEO is not Board Chair (independent Chair structure) and MOCC leadership is independent; clawback and misconduct recoupment policies add guardrails against windfalls or misstatement-related awards .
  • Forward indicators: February 2025 option grant increased to 204,910 shares (from 189,910 in 2024), expanding future alignment and potential realizable pay tied to stock performance through 2035; watch for Form 4s around vesting anniversaries for incremental exercise activity .